Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study

By sjmartinez • December 21, 2022

Kudo M, Finn RS, Qin S, Han KH, Ikeda K, Cheng AL, Vogel A, Tovoli F, Ueshima K, Aikata H, López CL, Pracht M, Meng Z, Daniele B, Park JW, Palmer D, Tamai T, Saito K, Dutcus CE, Lencioni R. Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study. J Hepatol. 2023 Jan;78(1):133-141. doi: 10.1016/j.jhep.2022.09.006. Epub 2022 Sep 20. PMID: 36341767.

Tags: Digestive Diseases, landmark analysis, lenvatinib, mRECIST, Publications, response status, surrogate endpoint

Deubiquitinase JOSD1 tempers hepatic proteotoxicity

Chowdhury S, Sen A, Das D, Chakrabarti P. Deubiquitinase JOSD1 tempers hepatic proteotoxicity. Cell Death Discov. 2024 Sep 16;10(1):405. doi: 10.1038/s41420-024-02177-y. PMID: 39284830.

Prevalence of Healthcare Barriers Among US Adults With Chronic Liver Disease Compared to Other Chronic Diseases

Wong CR, Crespi CM, Glenn B, May FP, Han SB, Bastani R, Macinko JA. Prevalence of Healthcare Barriers Among US Adults With Chronic Liver Disease[...]

Impact of Elevated Serum Triglycerides on Children with Acute Recurrent or Chronic Pancreatitis from INSPPIRE-2

Sellers ZM, Giefer MJ, Wang F, Cress GA, Abu-El-Haija MA, Chugh A, Cohen RZ, Downs EM, Fishman DS, Freeman AJ, Gariepy CE, Gonska TY, Grover[...]